An interventional study of personalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium in Delirium Prevention, sponsored by Vigorous Mind, Inc.. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Vigorous Mind, Inc. · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 263 studies in Delirium with a site in United States — 37 open to participants now, 60 under way, 7 of them phase 3. Delirium · United States.
Among the 263 studies in Delirium with a site in United States, this one is the 137th largest by planned enrollment of the 194 interventional ones that give a count, is one of 14 that started in 2026, is one of 105 with no phase, reaches primary completion later than 31 of the 59 other live ones, and was the 263rd registered.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
Browse Delirium studies →37 of the 263 studies in Delirium with a site in United States are open now. Recruiting first, the newest first:
The Methodist Hospital Research Institute · Sites in United States
Ages up to 65
Northwestern University · Sites in United States
Ages 18+
Ceribell Inc. · Sites in United States
Ages 18+
Washington University School of Medicine · Sites in United States
Ages 60+
Indiana University · Sites in United States
Ages 50+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
263 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 32 · Phase 3 25 · Phase 4 32
First in 2000; this study’s year is marked. 14 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 111 across 551 interventional studies indexed under Delirium.
Median enrollment 84 across the 194 interventional studies, 124 across the 69 observational. Of the 171 that completed or were terminated, 68 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 263 have an industry lead sponsor. The 10 most frequent:
Vigorous Mind, Inc. is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Vigorous Mind, Inc. has 1 study filed under Delirium — fewer than ten, so there is no comparison to draw.
22 of the studies in Delirium with a site in United States that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05431595Phase 3M.D. Anderson Cancer CenterManaging Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy | 2027-02-02 |
| NCT06969287Phase 3Washington University School of MedicineMitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery | 2027-04-01 |
| NCT06192615Phase 3Massachusetts General HospitalMinimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II) | 2027-10-31 |
| NCT03182335University of ChicagoVasopressor SAT Study | 2026-11 |
| NCT05127265University of FloridaPervasive Sensing and AI in Intelligent ICU | 2026-12 |
Add all 22 to your calendar (.ics) → With an account.
Among the 263 studies in Delirium with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a feasibility study. 20 non-ICU hospitalized patients at high risk of getting delirium will be consented and screened to receive a personalized multicomponent non-pharmacological intervention through an autonomous navigating robot at the bedside.
Inclusion criteria: High risk of delirium: Agr >80, dementia, High readmission risk score as calculated by EPIC, postoperative
Exclusion Criteria: Patients who screen positive for delirium by CAM Patients who are actively dying Patients who cannot perform the CAM due to language or advanced dementia or level of consciousness
-
Feasibility study of using an autonomous mobile robot to deliver a personalized multicomponent non-pharmacological intervention to prevent delirium at the bedside
Other: personalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium
personalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium
Robot correctly arrived at the bedside and greeted the patient
The robot has to navigate to the bedside of each patient at a scheduled time
Time frame: Two months of feasibility study
Robot correctly arrived at the bedside, oriented the patient and delivered the personalized multicomponent non-pharmacological intervention.
The robot has to identify the patient, get permission to talk to the patient and then deliver the orientation and engage the patient in a series of activities if the patient agrees.
Time frame: Two months of the feasibility study
Start is estimated for Nov 2026; primary completion for Apr 2027, 5 months later.
Of 222 interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 5 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vigorous Mind, Inc.